Medications

Saxenda Injections

Saxenda (liraglutide) helps you feel fuller for longer and was the first GLP-1 injection approved for weight loss.

While Saxenda works well, at Voy we focus on newer treatments like Wegovy (semaglutide) and Mounjaro (tirzepetide), which deliver even better results.

Find out today if you're eligible for these more effective options.

icon
icon

UK Licensed medication

icon
icon

Free next-day delivery

icon
icon

Ongoing support

icon
icon

UK Licensed medication

icon
icon

Free next-day delivery

icon
icon

Ongoing support

About Saxenda

What is Saxenda?

Saxenda, an MHRA-approved prescription medication, is designed to aid weight loss by regulating your appetite and balancing blood sugar levels.

Administered through a daily self-injection, Saxenda contains the active ingredient Liraglutide, which mimics a naturally occurring hormone that helps suppress appetite. By helping you feel fuller for longer, Saxenda supports sustainable weight management in conjunction with a healthy diet and regular exercise.

Doses

Saxenda dosing schedule

Saxenda is injected once daily at any time of the day. The dose should be gradually increased as outlined in the table, unless advised otherwise by our medical team. At the maximum dose, each pen lasts six days.

Voy members lose on average
icon
21.55%
body weight in 10 months
Based on a clinical study of  57,975 VOY participants in partnership with Imperial College London
See how much weight you could lose
95kg
With Voy you could lose
20.5kg

Built by leading obesity experts

clinician image

Dr. Earim Chaudry is a highly accomplished digital health doctor with extensive experience in the field of online and telemedicine-based healthcare. Over the years, he has played a pivotal role in shaping the landscape of digital healthcare in the UK.

Earim Chaudry, MD

Chief Medical Officer

clinician image

Phoebe Fox is a pharmacist independent prescriber with a diverse background in community pharmacy, primary care, and digital health. Passionate about weight management, she is particularly interested in its role in improving health conditions such as diabetes and high blood pressure.

Phoebe Fox, Mpharm, CEPIP

Weight Loss Specialist Prescriber

clinician image

Professor of Obesity and founder of MoreLife. He is CEO of Obesity UK and delivered over 400 presentations and scientific publications, and co-authored 7 book chapters on the topic of obesity.

Paul Gately

Professor of Obesity and Founder of MoreLife

In partnership with leading educational and research institutions

Our members experience transformational results

HEALTH IMPROVEMENT

97% of patients felt that their overall health had improved with Voy.

chart

WEIGHT LOSS

Patients lost 5 times more weight with Voy than with diet and exercise alone.

chart

In collaboration with leading educational and research institutions

Saxenda FAQ

Medically reviewed on July 14h, 2025.

Your first step towards weight loss starts here

Today can be life changing

Take the first step towards weight loss that lasts.

Take the first step towards weight loss that lasts.